News tagged with pfizer
Scientists from The Scripps Research Institute and Pfizer Inc. have published a new study showing how a new drug called tafamidis (Vyndaqel) works. Tafamidis, approved for use in Europe and currently under ...
Medical research May 29, 2012 | 5 / 5 (3) | 0 |
In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expect ...
Cancer Aug 09, 2011 | not rated yet | 0 |
Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...
Medications Dec 26, 2012 | not rated yet | 0
The study, published in PLOS Genetics on 20 December, adds to growing evidence that particular genes are involved in chronic pain and highlights this pathway as a potential target for more effective pain relief treatments for pa ...
Genetics Dec 20, 2012 | 5 / 5 (1) | 1 |
Between the blueprint of the genome and the products of its expression lie microRNAs, which can boost or lower the rate at which genes become stuff. In fact, many cancers use microRNA to magnify the expression of faulty genes ...
Cancer Dec 13, 2012 | 5 / 5 (1) | 0 |
Canada's top court on Thursday stripped Pfizer of its patent for Viagra, saying the pharmaceutical giant failed in the patent to identify the active compound in the drug.
Medications Nov 08, 2012 | not rated yet | 0
More than 100 years after it was first caught in the act of decaying a patient's brain, Alzheimer's remains one of medicine's greatest challenges as it robs ever more people of their memory and independence.
Alzheimer's disease & dementia Sep 17, 2012 | not rated yet | 1
An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.
Alzheimer's disease & dementia Sep 11, 2012 | not rated yet | 0
(AP) A closely watched experimental Alzheimer's treatment has failed to slow the disease in one late-stage study, a big disappointment for doctors and patients but not the end of the road for the drug. Pfizer Inc. ...
Alzheimer's disease & dementia Jul 23, 2012 | not rated yet | 0
Watching Alzheimer's disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. But a new pill formulated by a respected pharmaceutical company and approved by the Food ...
Alzheimer's disease & dementia Mar 23, 2012 | 5 / 5 (1) | 0
(HealthDay) -- Coffee and caffeine are not associated with psoriasis incidence after adjustment for smoking, according to a research letter published in the March issue of the Archives of Dermatology.
Diseases, Conditions, Syndromes Mar 21, 2012 | not rated yet | 1 |
Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase prescriptions, according ...
Medications Jun 27, 2011 | 5 / 5 (3) | 0 |
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be ...
Cancer May 23, 2011 | 5 / 5 (1) | 0 |
(HealthDay)—For patients with multiple cardiovascular risk factors or atherosclerotic vascular disease who have not had a myocardial infarction, daily treatment with n-3 fatty acids does not reduce cardiovascular ...
Cardiology May 09, 2013 | not rated yet | 0
Pfizer Inc., in a first for the drug industry, told The Associated Press that the drugmaker will begin selling its popular erectile dysfunction pill Viagra directly to patients on its website.
Medications May 06, 2013 | not rated yet | 0
Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), antibiotic Zithromax (azithromycin), Viagra (sildenafil citrate), and the anti inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside USA and Canada, mainly in South America).
Pfizer's shares were made a component of the Dow Jones Industrial Average on April 8, 2004.
On January 26, 2009, Pfizer agreed to buy pharmaceutical giant Wyeth for US$68 billion, a deal financed with cash, shares and loans.
For more information about Pfizer, read the full article at
This text uses material from Wikipedia and is available under the GNU Free Documentation License.